What it costs
Peptide Pricing and Cost Analysis
Prices normalised to cost per milligram and adjusted for purity, so vials of different sizes and grades can be compared directly.
In short
Headline prices are close to meaningless in this market because vial sizes, concentrations and purity all differ between suppliers. We index public vendor listings and normalise everything to price per milligram, then adjust for purity, because that is the only figure that lets you compare two offers honestly.
Below is how that calculation works, what actually drives the cost of a peptide, and the ranges we currently see across the market.
Why headline prices mislead
A vendor quoting $95 a vial and a vendor quoting $110 a vial are not necessarily offering you the same thing, or even a comparable thing. Vial sizes range from 2 mg to 50 mg, concentrations vary, and purity is rarely stated on the product page at all. The number on the listing answers a question nobody is actually asking.
The first correction is simple arithmetic: divide the price by the milligrams in the vial. A 20 mg vial at $40 costs $2.00 per milligram. A 10 mg vial at $25 looks cheaper on the shelf but works out to $2.50 per milligram, twenty-five percent more expensive. Vial size alone can reverse which offer is better.
Price per effective milligram
The second correction is the one almost nobody makes. If purity varies between two products, you are paying for the impurity fraction as well, so the honest figure is cost per effective milligram: price divided by the mass that is actually the target sequence.
A worked example from our retatrutide indexing shows how far this can move a decision. A 10 mg vial at $110 with 99.4 percent purity comes to $1.11 per effective milligram. A cheaper vial at $95 with 91 percent purity comes to $1.04 per effective milligram, so it is still nominally the better buy, but it carries a nine percent impurity load into whatever you do with it.
Whether that trade is worth making is a judgement about the work, not about the price. The point is that a per-milligram figure hides it entirely, and a per-effective-milligram figure puts it in front of you.
What actually drives the cost
Peptide pricing is not arbitrary, even where it looks it. Four things move it:
- Sequence length and complexity. Each additional amino acid is another coupling step with its own yield loss. A fifteen-residue peptide like BPC-157 is cheap to make; a long triple agonist is not.
- Purification depth. Getting from 95 to 99 percent purity costs disproportionately more than getting to 95 in the first place, because the last few percent are the hardest to remove.
- Analytical verification. Independent HPLC and mass spectrometry on every batch is a real per-batch cost. Vendors who skip it are genuinely cheaper to run.
- Grade and intent. A certified analytical reference standard and bulk research material are different products sold for different purposes, and the price gap between them is legitimate rather than suspicious.
This is why a low price is not automatically a red flag, and a high price is certainly not a guarantee. What matters is whether the price is explained by something you can verify.
Ranges we currently see
Figures below come from our own indexing of public vendor listings. Prices move often, so treat them as orientation rather than as quotes.
| Compound | Observed range | What the spread tells you |
|---|---|---|
| Retatrutide | ~$300 per 1 mg reference standard, down to ~$375 per 30 mg vial | The widest spread we track. Grade differences explain part of it, loose labelling explains the rest. |
| TB-500 | $0.50 to $12.40 per mg; 5 mg vial $60–70 at established suppliers | A twenty-five fold spread with little correlation to the analytical data supplied. |
| BPC-157 | ~$34.99 per 5 mg vial | Cheap and high volume, which shifts the risk from impurity toward under-filling and substitution. |
| GHK-Cu | Average ~$9.91 per unit, full range $0.07 to $89 | At the low end shipping of $15–35 can exceed the price of the material itself. |
| NAD+ | ~$2.00 to $2.50 per mg depending on vial size | A clean illustration of vial size reversing which listing is cheaper. |
When a low price is worth a second look
The useful way to think about a suspiciously cheap listing is to price the alternative. Independently re-testing a batch through a third-party laboratory typically runs $300 to $500 per sample. If the saving on the vial is $15 and the doubt it creates would cost $400 to resolve, the saving is not real.
That framing also tells you when cheap is fine. If a vendor publishes a current, batch-matched certificate from a named laboratory, a low price is just a low price.
Compare landed cost, not catalogue price
Shipping is frequently structured to move behaviour rather than to cover cost. Charges of $15 to $35 per order are normal, and free-shipping thresholds around $150 quietly push buyers toward larger orders than they need, which means committing more money to a single unverified batch.
Add shipping, any payment surcharge and, where relevant, the cost of your own verification before comparing two vendors. The ranking changes more often than you would expect.
Prices on this page are indexed from public vendor listings and change frequently. Nothing here is medical advice or a recommendation to purchase any compound. See our editorial policy for how we index and correct this data.
Pricing analysis
-
Semaglutide for Research Purposes: A 2026 Analytical Cost and Market Analysis
Selecting a vendor based solely on a $20.00 entry price for 2mg vials often masks the systemic risks of acquiring…
-
Retatrutide Research Price Analysis: A 2026 Data-Driven Guide for Investigators
Does a 17-step synthesis process justify a 400 percent price variance between laboratory suppliers? As an investigator, you recognize that…
-
TB-500 Research Grade Price: 2026 Market Analysis and Comparison Framework
With the global peptide therapeutics market projected to reach $53.8 billion in 2026, the volatility of the TB-500 research grade…
-
How to Compare Research Peptide Prices: A 2026 Data-Driven Analytical Framework
The global peptide therapeutics market is anticipated to reach $163.98 billion in 2026, yet the methodology for evaluating the fiscal…
-
How to Budget for Peptide Purchases in a Lab: A 2026 Data-Driven Framework
The true cost of a peptide is rarely the figure listed on a vendor’s initial invoice. It is more accurately…
-
PeptidePrice vs. Analytical Intelligence: A Researcher’s Guide to Cost-Efficiency
Relying solely on a peptideprice aggregator to secure research materials is a tactical oversight that often prioritizes immediate savings over…
-
Adipotide Peptide Price Comparison: A 2026 Analytical Guide for Researchers
In the current research landscape, a single 10mg vial of Adipotide (FTPP) can fluctuate in price by over 135% between…
-
Amino Asylum Peptide Prices Compared: A 2026 Data-Driven Analysis
The lowest sticker price on a peptide vial often represents the most expensive path for a laboratory’s longitudinal budget. While…
-
Retatrutide Peptide Price Comparison: A 2026 Analytical Research Guide
The most affordable acquisition cost for an investigational triple-agonist often represents the most significant risk to your laboratory’s data…
-
Peptide Prices in 2026: An Analytical Guide to Market Valuation and Research Costs
A March 2026 study revealed that 18% to 22% of commercially available peptides exhibit significant batch-to-batch variability. This inconsistency…
-
How to Compare Research Peptide Prices Online: A Data-Driven Analytical Framework
With Google searches for the cost of peptide therapy increasing by 300% between April 2025 and April 2026, the pursuit…
-
Peptide Price Comparison Tool: An Analytical Guide for Researchers
The pursuit of the lowest price per milligram often leads to a catastrophic compromise in molecular purity that invalidates months…
-
Retatrutide Price Analysis: 2026 Market Trends and Research Costs
The synthesis of a triple-agonist peptide like retatrutide involves a complex 39 amino acid sequence, making its production significantly more…
-
The Hidden Risks of Buying Cheap Peptides Online: A 2026 Analytical Review
A 2025 analytical audit of independent laboratory data revealed that 42% of budget-tier peptide vials contained residual trifluoroacetic acid levels…